Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Ruggiero

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of the American Society of Nephrology : JASN|May 11, 2017
Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous NephropathyJan A J G van den Brand, Piero Ruggenenti, Antonietta Chianca, et al.
Rheumatology (Oxford, England)|April 28, 2020
Comment on: European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiativeLouise Oni, Jenna F Gritzfeld, Caroline Jones, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2013
Lupus nephritis in children and adolescents: results of the Italian Collaborative StudyBarbara Ruggiero, Marina Vivarelli, Alessandra Gianviti, et al.
Journal of the American Society of Nephrology : JASN|February 1, 2014
Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndromePiero Ruggenenti, Barbara Ruggiero, Paolo Cravedi, et al.
Rheumatology (Oxford, England)|August 27, 2010
Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patientsFederica Capolunghi, Maria M Rosado, Simona Cascioli, et al.
Diabetes|September 17, 2016
Renal and Systemic Effects of Calorie Restriction in Patients With Type 2 Diabetes With Abdominal Obesity: A Randomized Controlled TrialPiero Ruggenenti, Manuela Abbate, Barbara Ruggiero, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2019
Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized TrialBarbara Ruggiero, Matias Trillini, Lida Tartaglione, et al.
The Lancet. Diabetes & Endocrinology|November 7, 2017
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trialAneliya Parvanova, Matias Trillini, Manuel A Podestà, et al.
Kidney International|November 5, 2020
Results of the PROPINE randomized controlled study suggest tapering of prednisone treatment for relapses of steroid sensitive nephrotic syndrome is not necessary in childrenAntonio Gargiulo, Laura Massella, Barbara Ruggiero, et al.
Diabetes, Obesity & Metabolism|February 23, 2019
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trialPiero Ruggenenti, Matias Trillini, Drazenka P Barlovic, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of the American Society of Nephrology : JASN|May 11, 2017
Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous NephropathyJan A J G van den Brand, Piero Ruggenenti, Antonietta Chianca, et al.
Rheumatology (Oxford, England)|April 28, 2020
Comment on: European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiativeLouise Oni, Jenna F Gritzfeld, Caroline Jones, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2013
Lupus nephritis in children and adolescents: results of the Italian Collaborative StudyBarbara Ruggiero, Marina Vivarelli, Alessandra Gianviti, et al.
Journal of the American Society of Nephrology : JASN|February 1, 2014
Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndromePiero Ruggenenti, Barbara Ruggiero, Paolo Cravedi, et al.
Rheumatology (Oxford, England)|August 27, 2010
Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patientsFederica Capolunghi, Maria M Rosado, Simona Cascioli, et al.
Diabetes|September 17, 2016
Renal and Systemic Effects of Calorie Restriction in Patients With Type 2 Diabetes With Abdominal Obesity: A Randomized Controlled TrialPiero Ruggenenti, Manuela Abbate, Barbara Ruggiero, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2019
Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized TrialBarbara Ruggiero, Matias Trillini, Lida Tartaglione, et al.
The Lancet. Diabetes & Endocrinology|November 7, 2017
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trialAneliya Parvanova, Matias Trillini, Manuel A Podestà, et al.
Kidney International|November 5, 2020
Results of the PROPINE randomized controlled study suggest tapering of prednisone treatment for relapses of steroid sensitive nephrotic syndrome is not necessary in childrenAntonio Gargiulo, Laura Massella, Barbara Ruggiero, et al.
Diabetes, Obesity & Metabolism|February 23, 2019
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trialPiero Ruggenenti, Matias Trillini, Drazenka P Barlovic, et al.
Pageof 4